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Abstract
The mixed effects model for repeated measures (MMRM) has been widely used for the analysis of
longitudinal clinical data collected at a number of fixed time points. We propose a robust extension
of the MMRM for skewed and heavy-tailed data on basis of the multivariate skew-t distribution, and
it includes the multivariate normal, t, and skew-normal distributions as special cases. An efficient
Markov chain Monte Carlo algorithm is developed using the monotone data augmentation and
parameter expansion techniques. We employ the algorithm to perform controlled pattern imputations
for sensitivity analyses of longitudinal clinical trials with nonignorable dropouts. The proposed
methods are illustrated by real data analyses. Sample SAS programs for the analyses are provided
in the online supplementary material.
Keywords
Block sampling; Controlled imputations; Mixed effects model for repeated measures; Monotone data
augmentation; Penalized complexity prior; Tipping point analysis
1 Introduction
The mixed effects model for repeated measures (MMRM) has been commonly used for the primary
analysis of longitudinal continuous outcomes in clinical trials1,2. As recommended by the regulatory
guidelines3,4, the main analysis in clinical trials shall be unambiguously prespecified in the protocol.
For this reason, the observations within a subject are usually assumed to follow a multivariate normal
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distribution with an unstructured covariance matrix in MMRM1,2,5,6. If the covariance structure is
misspecified, the treatment effect estimate may be biased in the presence of missing data7, and the test
for the fixed effects may not be able to control the type I error rate8,9. A covariance selection approach
using Akaikes information criterion or Schwarzs Bayesian information criterion also tends to inflate the
type I error rate10.
The controlled imputation methodology11–14 has become increasingly popular in sensitivity analyses
of longitudinal trials with nonignorable dropouts. The controlled imputation and MMRM assume the
same observed data distribution, but specify different mechanisms for missingness due to dropout. The
MMRM assumes the data are missing at random (MAR15). It implies that subjects who discontinue
the treatment early have the same mean response profiles as subjects who complete the trial. The
MAR mechanism may not be convincing if the dropout is due to adverse events or inadequate efficacy.
Sensitivity analyses under missing not at random (MNAR15) are recommended by recent regulatory
guidelines16,17 and a FDA-mandated panel report from the National Research Council18. Under MNAR,
the response profiles differ systematically between dropouts and completers. In the controlled imputation,
the mean outcomes among subjects in the experimental arm after dropout are assumed to be similar to
that of control subjects, or get worse compared to subjects who stay on the treatment. The assumption is
clinically plausible and easy to understand. If the treatment effect remains significant in a conservative
nonignorable sensitivity analysis, we can claim the robustness of the primary conclusion obtained under
MAR.
The controlled imputation specifies a pattern mixture model (PMM19) for the longitudinal outcomes
in the sense that their joint distribution depends on the dropout time. The controlled imputation is
generally implemented via multiple imputation (MI), and this will be explained in Section 7. Tang14,20
introduces a formal Markov chain Monte Carlo (MCMC) algorithm to conduct the controlled imputation
based on the monotone data augmentation (MDA) strategy. It extends and improves Schafer’s21 MDA
algorithm for multivariate normal outcomes. The algorithm is unaffected by the dropout mechanism.
The missing data after dropout are integrated out of the posterior distribution, and imputed after the
algorithm converges. Only the intermittent missing outcomes and the model parameters are drawn
iteratively before the Markov chain reaches its stationary distribution. It imputes fewer missing values,
and tends to converge faster with smaller autocorrelation between posterior samples than an algorithm
that imputes all missing outcomes in each iteration20,21. Tang22,23 develops the controlled imputation for
longitudinal outcomes with potentially different types of variables based on the factored likelihood, in
which the conditional model of the outcome at each visit given the outcomes at previous visits can be
linear, binary logistic, multinomial logistic, proportional odds, Poisson, negative binomial, skew-normal
(SN24) or skew-t (ST25) regressions, and may vary by visits.
The main purpose of this article is to extend the controlled imputation to non-normal longitudinal
continuous outcomes. In the mixed effects model, inference about the fixed effects is asymptotically
valid for non-normal outcomes26, but may suffer from some loss of efficiency27,28 in large samples.
The inference is vulnerable to severe departures from normality in small and moderate samples29, and
this can be easily understood in the simple case of a t test30. Furthermore, imputing skewed outcomes
under normality leads to biased MI estimates of the distributional shape parameters31. We relax the
normality assumption in MMRM by modeling the within subject dependence using the multivariate ST
distribution25, which includes the multivariate SN32, normal and t distributions as special cases. This
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extension is different from our previous work23, where the data are modeled by a sequence of univariate
ST regressions.
The SN and ST distributions have a roughly bell-shaped density, and can be made arbitrarily close
to the normal or t density by regulating suitable parameters25. They are also capable of accommodate
asymmetry and heavy tails often exhibited in clinical data33–35. In the SN and ST distributions, the
skewness is partially induced by truncating some latent variables36,37. Such selection or truncation
mechanisms arise naturally in clinical studies. For example, a clinical trial may enroll only patients whose
disease severity is above a certain level. In Section 2, we briefly review the univariate and multivariate
SN and ST distributions, and derive the relevant conditional distribution.
The SN and ST distributions present some undesirable properties in statistical inference38–40. This can
be illustrated in the univariate regression. In the scalar case, the asymptotic distribution of the maximum
likelihood estimate (MLE) is bimodal when the distribution of the data is close to normal, and there is
a non-negligible chance that the MLE of the skewness parameter can be infinite for skewed data41,42.
Similar issues exist in Bayesian inference38,43. In general, the likelihood function changes slowly at large
values of the skewness and/or degrees of freedom (df) parameters, and converges to a constant when the
skewness and/or df parameters reach their limit values (all other parameters are fixed). As a result, the
posterior distribution in Bayesian inference may be improper under a diffuse prior, and the posterior
estimates of the skewness and/or df parameters can be sensitive to the decay rate of their marginal
prior densities33,38,44. The problems become even more complex in the multivariate case. Section 3.1
investigates how to specify the priors for the skewness, df and covariance parameters to address the
inference challenges mentioned above.
In Sections 3.2 and 4, we extend Tang’s MDA algorithm14,20 to the multivariate ST, SN and t
regressions. The underlying idea is to reorganize these robust regressions as the normal linear regression
with the introduction of some latent variables. The parameter expansion (PX45,46) and block sampling
techniques are employed to improve the mixing and accelerate the convergence of the Markov chain.
Section 5 applies the MDA algorithm to the controlled imputation. The proposed MDA algorithm and
missing data imputation methods are illustrated by real data analyses in Section 6.
Throughout the article, the following notations will be used. Let G(a, b) denote a gamma distribution
with shape a, rate b and mean a/b. Let N(µ,Ω) denote the normal distribution with mean µ and
covariance Ω, and t(µ,Ω, ν) the t distribution with ν df. In the multivariate case, µ is a vector and Ω is
a square matrix. The probability density functions (PDF) of the gamma, normal and t distributions are
denoted, respectively, by G(·|·), N(·|·) and t(·|·). Let Φ(·) and Tν(·) denote respectively the cumulative
distribution function (CDF) of N(0, 1) and t(0, 1, ν). Let N+(µ, σ2) be the scalar positive normal
distribution left truncated at 0, and t+(µ, σ2, ν) the scalar positive t distribution. Let W−1(A, n0) denote
the inverse Wishart distribution with PDF π(Σ) ∝ |A|n0/2|Σ|−(n0+p+1)/2 exp[−tr(AΣ−1)/2].
2 Review of univariate and multivariate SN and ST distributions
We review the univariate and multivariate SN and ST distributions introduced by Azzalini and his
collaborators24,25,32. We focus on their convolution-type stochastic representation25,47 as it allows
straightforward interpretation of the skewness parameters in the multivariate distribution (see Section 2.2
below), and makes it easier to design the MCMC algorithm48. An alternative stochastic representation is
given by Azzalini and Capitanio25. In both representations, the skewness is induced by truncating a latent
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variable36. Such mechanism arises naturally in practice. For example, in clinical trials, patients may be
selected only if a variable of interest is above a threshold.
2.1 Univariate SN and ST distributions
The PDF of a SN24 random variable y ∼ SN (µ, σ2, ψ) is given by 2N(y|µ, ω2)Φ[λ(y − u)/ω], where
ω2 = σ2 + ψ2. It can be stochastically represented as
y = µ+ ψW + ǫ,
where µ is the location parameter,W ∼ N+(0, 1) is independent of ǫ ∼ N(0, σ2), and λ = ψ/σ is the
skewness parameter. Its mean is E(y) = µ+ ψ
√
2
pi .
The parameter λ controls the degree to which the data depart from normality. When λ = 0, the SN
distribution reduces to the normal distribution. The degree of the skewness of y increases as the absolute
value of λ increases. Since the maximum skewness and kurtosis are 0.995 and 0.869 respectively24, the
SN distribution is suitable only for mildly or moderately non-normal data.
The ST distribution25 allows a higher degree of skewness and kurtosis. A ST random variable
y ∼ ST (µ, σ2, ψ, ν) can be stochastically represented as
y = µ+
1√
d
[ψW∗ + ǫ] = µ+ ψW + 1√
d
ǫ, (1)
where d ∼ χ2ν/ν [i.e. d ∼ G(ν/2, ν/2)], W∗ ∼ N+(0, 1), W =W∗/
√
d ∼ t+(0, 1, ν) and ǫ ∼
N(0, σ2). We get E(y) = µ+ ψ
√
ν
pi
Γ((ν−1)/2)
Γ(ν/2) , where Γ(·) is the gamma function. The PDF of y is
given by
f
ST
(y|µ, ω2, λ, ν) = 2t(y|µ, ω2, ν)Tν+1
[
λ
y − µ
ω
√
ν + p
ν + (y−µ)
2
ω2
]
. (2)
2.2 Multivariate SN and ST distributions
A multivariate version of the SN distribution is introduced by Azzalini and Dalla Valle32. The random
vector y = (y1, . . . , yp)
′ ∼ SN (µ,Σ,ψ) can be represented as48
(y1, . . . , yp)
′ = µ+ψW + ǫ (3)
where ǫ = (ǫ1, . . . , ǫp)
′ ∼ N(0,Σ), W ∼ N+(0, 1), µ = (µ1, . . . , µp)′ is a vector containing the
location parameters, and ψ = (ψ1, . . . , ψp)
′ is a vector of skewness parameters. The PDF of y is given
by
f
SN
(y|µ,Σ,ψ) = 2N(y|µ,Ω)Φ[λ∗′(y − µ)] = 2N(y|µ,Ω)Φ

 p∑
j=1
λj
yj − µj
ωj

 , (4)
where ω2j is the (j, j)th element of Ω = Σ+ψψ
′, and λ∗ =
(
λ1
ω1
, . . . ,
λp
ωp
)
= Ω
−1ψ√
1−ψ′Ω−1ψ =
Σ−1ψ√
1+ψ′Σ−1ψ
.
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The multivariate SN distribution32 was originally introduced through the parametrization
(µ, λ1, . . . , λp,Ω). It is difficult to interpret the skewness parameter λj , which does not provide
information about the skewness of yj , not even on its sign
42. Also, Ω is not the covariance matrix of y.
LetΣjj = var(ǫj). By the stochastic representation (3), the marginal distribution of yj = µj + ψjW + ǫj
is SN(µj ,Σjj , ψj), and its skewness is controlled by ψj/
√
Σjj .
The multivariate ST distribution25 y ∼ ST (µ,Σ,ψ, ν) can be represented as
(y1, . . . , yp)
′ = µ+ψW + 1√
d
ǫ, (5)
where d ∼ χ2ν/ν,W∗ ∼ N+(0, 1) andW =W∗/
√
d ∼ t+(0, 1, ν). The PDF of y is
f
ST
(y|µ,Σ,ψ, ν) = 2t(y|µ,Ω, ν)Tν+p
[
λ∗
′
(y − µ)
√
ν + p
ν + (y − µ)′Ω−1(y − µ)
]
. (6)
Let the LDL decomposition of Σ be denoted by Σ = LΛL′, where Λ = diag(γ−11 , . . . , γ
−1
p ), L =
U−1, and U =


1 0 . . . 0
−β21 1 . . . 0
−βp1 . . . −βp,p−1 1

. Equation (5) can be reorganized as Uy = Uµ+ UψW +
1√
d
Uǫ or equivalently as
yj =
j−1∑
t=1
βjtyt + µj + ψjW +
εj√
d
for j = 1, . . . , p, (7)
where (µ
j
, ψ
j
) = (µj , ψj)−
∑j−1
t=1 βjt(µt, ψt), and εj’s are independently distributed as εj ∼
N(0, γ−1j ).
It is well known25,32 that the conditional distribution of ys2 = (ys+1, . . . , yp)
′ given ys1 =
(y1, . . . , ys)
′ is no longer the SN/ST distribution. As shown in Lemma 1 below, the conditional
distribution of ys2 given ys1 can be expressed similarly to Equation (7) except that the location parameter
for the positive normal or t random variable is not 0. We omit the proof since a more general result is
given in Appendix A.1.1.
Lemma 1. (a) The conditional distribution of (d,W) given ys1 = (y1, . . . , ys)′ is
W|y1, . . . , ys ∼ t+
[
B
A
,
νd
A(ν + s)
, ν + s
]
and
d|W , y1, . . . , ys ∼ G
[
ν + s+ 1
2
,
νd +A(W − BA )2
2
]
,
(8)
where y∗j = yj −
∑j−1
t=1 βjtyt − µj , A = 1 +
∑s
j=1 γjψ
2
j
, B =
∑s
j=1 γjψjy
∗
j and νd =
ν +
∑s
j=1 γjy
∗2
j −B2/A.
(b) The conditional distribution of ys2 given ys1 can be represented as a sequence of univariate
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conditional distributions
yj =
j−1∑
t=1
βjtyt + µj + ψjWs +
1√
ds
εj for j ≥ s+ 1,
where εk ∼ N(0, γ−1k ), εk’s are independent, and (Ws, ds) is the random sample from the conditional
distribution (8).
(c) The conditional distribution of ys2 given ys1 can be equivalently represented in matrix form as
ys+1. . .
yp

 =

µs+1. . .
µp

− U−1s22Us12

y1 − µ1. . .
ys − µs

+ U−1s22

ψs+1. . .
ψ
p

Ws + U−1s22√
ds

εs+1. . .
εp

 ,
where
[
Us11 0
Us21 Us22
]
=


1 0 0 . . . 0
. . .
−βs1 . . . 1 . . . 0
. . . . . . . . . 0
−βp1 . . . −βps . . . 1

 is a partition of U .
Notes:
1. In Lemma 1(a), the conditional distribution of d given y1, . . . , ys is not gamma due to the constraint
W > 0.
2. Lemma 1 can be applied to the multivariate SN distribution by setting ν ≡ ∞, d ≡ 1 and W|ys1 ∼
N+(BA ,
1
A ).
3. In the multivariate t distribution (ψj ≡ 0), the conditional distribution of ys2 given ys1 can be written
as yj =
∑j−1
t=1 βjtyt + µj +
εj√
ds
for j > s, where ds ∼ χ
2
ν+s
ν+
∑
s
t=1 γty
∗2
t
.
4. The skewness of the conditional distribution of ys+1 given y1, . . . , ys is a monotone function ofψj
√
γj .
3 MDA algorithm for MMRM with no restriction on fixed effects
Suppose a study consists of ntot subjects, and the data are collected at p fixed time points. Let
yi = (yi1, . . . , yip)
′ denote the complete outcome for subject i. In general, yi’s won’t be fully observed.
Let si be the last visit that subject i has a measurement observed, and si = 0 if the subject has no observed
outcome. Let yio, yim and yiw denote respectively the observed data with oi elements, intermittent
missing data with mi = si − oi elements prior to dropout, and missing data after dropout for subject i.
Without loss of generality, we sort the data so that subjects in pattern s are arranged before subjects in
pattern t if s > t. Let nj be the total number of subjects in patterns j, . . . , p. Let n = n1 be the number
of subjects with at least one observed outcome.
The following MMRM is often used to analyze longitudinal outcomes collected at a number of fixed
time points1,5
yij =
q∑
k=1
αkjxik + ξij for j = 1, . . . , p, (9)
where i = 1, . . . , ntot indexes subjects, q is the number of baseline covariates, αkj is the effect of
covariatexik at visit j, and ξi = (ξi1, . . . , ξip)
′ ∼ N(0,Ω). Let xi1 ≡ 1 if the model contains an intercept
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term. In clinical trials, we set the treatment status as xiq = gi = 1 for the experimental treatment, and
gi = 0 for the control treatment. We place no constraints on the covariate effects αkj ’s, and they can vary
freely over time. As discussed in Section 1, we employ an unstructured covariance matrix. It generally
provides a good control of the type I error rate under the null hypothesis, and results in a negligible loss in
efficiency7 under the alternative hypothesis when compared to the analysis based on the true covariance
structure (it is difficult to be prespecified) in moderate to large samples. A structured covariance matrix,
which may be induced through the use of random effects, is useful when individuals have a large number
of observations, or varying times of observations5.
Model (9) assumes that the outcomes are normally distributed. Inference about the treatment effect
based on the normality assumption can be inefficient in the presence of outliers27,28, and may be
invalid for highly non-normal data particularly when the sample size is small29. In this article, we
use the multivariate t, SN or ST distribution to model skewed and/or fat-tailed data. Model (9) will
be denoted respectively by MMRM-n, MMRM-t, MMRM-sn or MMRM-st when the residual errors
ξi = (ξi1, . . . , ξip)
′ are modeled by the multivariate normal, t, SN or ST distribution.
By introducing the latent variables (di,Wi), we can expand the MMRM-st as
yij =
q∑
k=1
αkjxik + ψjWi +
1√
di
ǫij =
Q∑
k=1
αkjxik +
1√
di
ǫij , (10)
where di ∼ G(ν/2, ν/2), W∗i ∼ N+(0, 1), Wi = W∗i /
√
di, Q = q + 1, αQj = ψj , and xiQ = Wi. The
MMRM-sn and MMRM-t can be obtained by setting di ≡ 1 (i.e. ν ≡ ∞) and ψj ≡ 0 respectively in
model (10).
Model (10) can be reorganized as the product of the following conditional models
yij ∼ N
(
Q∑
k=1
αkjxik +
j−1∑
t=1
βjtyit, (diγj)
−1
)
for j = 1, . . . , p, (11)
where αkj = αkj −
∑j−1
t=1 βjtαkt. Note that αQj = ψj = ψj −
∑j−1
t=1 βjtψt.
3.1 The prior distribution
We assume that ν and (Σ,α, ψ
1
, . . . , ψ
p
) are independent, and that α, ψ
1
, . . . , ψ
p
are conditionally
independent given Σ in the prior distribution, where α =

α11 . . . αq1. . .
α1p . . . αqp

. We use noninformative
or objective priors in our numerical examples, but our specification allows informative priors. The
missing data imputation is based on model (11) with the parameterization {ν, (θ1, γ1), . . . , (θp, γp)},
where θj = (α1j , . . . , αQj , βj1, . . . , βjj−1)
′. The prior on (θj , γj)’s can be induced from the prior on
(Σ,α, ψ
1
, . . . , ψ
p
). It is also possible to place priors directly on (θj , γj)’s.
3.1.1 Prior on Σ We employ the hierarchical prior introduced by Huang and Wand49
ρj
i.i.d∼ G
(
1
2
,
1
a20
)
and Σ|ρ1, . . . , ρp ∼W−1(Aw, nw),
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where nw = n0 + p− 1, Aw = 2n0 diag(ρ1, . . . , ρp). It is an extension of the half-t prior50 used in a
hierarchical model of variance parameters. The choice of n0 = 2 and a large value for a0 (e.g. a0 = 10
5)
corresponds to highly noninformative half-t priors on each standard deviation term and uniform priors on
each correlation term49.
The inverse Wishart distribution W−1(Aw , nw) with fixed Aw and nw is commonly used as the prior
for Σ in the multivariate normal and t linear regressions21,33,51. It reduces to Jeffrey’s prior at nw = 0
and Aw = 0. The inverse Wishart or Jeffrey’s prior can be quite informative or inappropriate in the
multivariate SN and ST regression for highly skewed data, and the argument is the same as that in the
univariate regression23.
3.1.2 Prior on the skewness parameters In the scalar case, the Bayes estimate of the skewness
parameter λ = ψ
√
γ can be infinite under a diffuse prior since there is a non-negligible chance that
the likelihood function is a monotone function of λ at fixed (µ, ω2). The issue can be resolved by using
the objective prior for λ38,39. The prior has no closed-form expression, but can be well approximated38,40
by λ ∼ t(0, π2/4, 1/2), or equivalently by ψ|γ ∼ t(0, π2/4γ, 1/2). No appropriate objective prior has
been developed in the multivariate case40. We set the prior ψ
j
|Σ ∼ t(0, π2/4γj, 1/2) for the skewness
parameter ψ
j
of y
ij
, and assume ψ
j
’s are conditionally independent given Σ in the prior. The prior is
equivalent to the following hierarchical prior
djψ ∼ G
(
1
4
,
1
4
)
and ψ
j
|Σ, djψ ∼ N
(
0,
π2
4djψγj
)
for j = 1, . . . , p.
Liseo and Parisi43 specifies a prior that requires certain constraints on the skewness parameters ψj’s to
make Ω positive definite43, and assumes conditional independence among the skewness parameters ψj’s
for yij’s given Σ. Our prior is more convenient to use, and might be more reasonable since yij’s tend to
be less correlated than yij ’s.
3.1.3 Prior on α Suppose the prior for α is
vec(α)|Σ ∼ N(vec(α0),M+ ⊗ Σ),
whereM is a given q × q covariance matrix with rank r∗, andM+ is the Moore-Penrose inverse ofM .
We allow M to be degenerate51. If all elements in the k-th column of α0, and all elements in the k-th
row and k-th column ofM are 0, the prior for the effects (αk1, . . . , αkp) of covariate xik is flat. We set
M = 0 and α0 = 0 in our examples.
3.1.4 Prior on (θj , γj)’s The prior on (θ1, γ1, . . . , θp, γp) can be induced from the prior on
(α, ψ
1
, . . . , ψ
p
,Σ). By Lemma 2 of Tang51, we get
djψ ∼ G(1/4, 1/4) and π(θj , γj) ∝ γ
nw+2j+r−p−1
2 −1
j exp
[
−γj
2
θ˜′jEj θ˜j
]
(12)
for j = 1, . . . , p, where θ˜j = (−θ′j , 1)′, E =

 M 0 Mα
′
0
0
′ 4djψ
pi2 0
′
α0M 0 α0Mα
′
0 +Aw

 is a (Q+ p)× (Q+ p)
matrix, Ej is the (Q+ j)× (Q+ j) leading principle submatrix of E, and r = r∗ + 1 is the rank of
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the matrix diag(M,
4djψ
pi2 ). Since α0 = 0 andM = 0, we get r
∗ = 0 and r = 1. We do not recommend
specifyingM by a diagonal matrix with small diagonal elements because γj’s tend to be overestimated
particularly in small samples since the shape parameter of the posterior gamma distribution of γj will
increase by r∗/2 = q/2, but the rate parameter changes little.
3.1.5 Prior on ν In the Student’s t regression, the likelihood function converges to a constant as ν →∞
(other model parameters are fixed) since the t distribution converges to the Gaussian distribution. As a
result, the posterior distribution of ν is proper only if the decay rate of the prior density of ν satisfies
certain conditions, and inference on ν is quite sensitive to the shape of the prior density of ν 33,44. The
same issue exists for the ST regression because the ST distribution converges to the SN distribution as
ν →∞.
We use the penalized complexity (PC) prior52 since it shows good performance in the Student’s
t regression in simulation. It is obtained by penalizing the complexity between the multivariate t
distribution t(µ, ν−2ν Σ, ν) and the normal distributionN(µ,Σ). The density of the PC prior is determined
numerically in Simpson et al52. Its analytic expression is derived in Appendix A.1.4
π(ν)=λ exp(−λd(ν))
∣∣∣∣∂d(ν)∂ν
∣∣∣∣ ,
whereΨ(·) and Ψ′(·) are the digamma and trigamma functions, b(ν) = Ψ(ν+p2 )−Ψ(ν2 ),
d(ν) =
√
p
[
1 + log
(
2
ν − 2
)]
+ 2 log
Γ(ν+p2 )
Γ(ν2 )
− (ν + p)b(ν) and
∂d(ν)
∂ν
= −
p
ν−2 +
ν+p
2 [Ψ
′(ν+p2 )−Ψ′(ν2 )]
2d(ν)
.
Tang23 gives the analytic density when p = 1, where ∂d(ν)∂ν is wrongly written as
...
4d(ν) (detected by Dr
Rue), but it does not affect the MCMC sampling and inference results. In the PC prior, ν is bounded
below by νl = 2. We also put an upper bound νm = 1000 on ν since the PDF can not be accurately
calculated due to rounding errors at large values of ν. Another popular prior for ν is the reference prior
given by Fonseca et al44.
3.2 MDA algorithm
The joint posterior distribution of φ = {(θ1, γ1, d1ψ , ρ1), . . . , (θp, γp, dpψ , ρp)}, ν and (di,Wi,yim)’s
is given by
π(Ym, di’s,Wi’s,φ, ν|Yo)
∝ π(ν)π(φ)

 n∏
i=1
f(di,Wi|ν)
p∏
j=1
ni∏
i=1
f(yij |yi1, . . . , yij−1, di,Wi,φ, ν)

 , (13)
where Yo = {yio : i = 1, . . . , n}, Ym = {yim : i = 1, . . . , n}, the last term in the bracket is the
likelihood for the augmented data (di’s,Wi’s, Yo, Ym), and
f(di,Wi|ν) ∝ d
ν+1
2 −1
i exp[−di
ν +W2i
2
],
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f(yij |yi1, . . . , yij−1, di,Wi,φ, ν) ∝
√
diγj exp
[
− diγj(yij −
∑
Q
k=1 αkjxik −
∑j−1
t=1 βjtyit)
2
2
]
,
π(φ) ∝
p∏
j=1
{
ρ
1+nw
2 −1
j exp(−
ρj
a20
)d
1
4−1
jψ
exp(−djψ
4
)γ
nw+2j+r−p−1
2 −1
j exp
[
−γj
2
θ˜′jEj θ˜j
]}
.
In the MDA algorithm, the missing data yiw after dropout are integrated out of the posterior
distribution, and imputed after the algorithm converges. The details will be given in Section 5. Subjects
without any observed outcomes (i.e. in pattern 0) will not be used in the posterior sampling of the model
parameters and (yim, di,Wi)’s.
The MDA algorithm for MMRM-st repeats the following steps until convergence
P0. Update ρj’s from its posterior distribution G(n0+p2 , n0
∑p
k=j γkβ
2
kj +
1
a20
)
P1. Update (dψj , θj , γj)’s by drawing dψj from G(34 , 14 + 2pi2 γjψ2j), and (θj , γj) from the gamma-
normal posterior distribution using Tang’s method23,51
π(θj , γj |φ, ν, Ym, Yo) ∝ γ
nj+nw+r+2j−p−3
2
j exp
[
−
γjθ˜
′
j(
∑
i≤nj dix˜ijx˜
′
ij + Ej)θ˜j
2
]
, (14)
where x˜ij = (xi1, . . . , xiQ, yi1, . . . , yij)
′.
P2. Update ν by a MH sampler with the proposal distribution log(ν∗ − νl) ∼ N [log(ν − νl), c2]. The
parameter c is tuned to make the acceptance probability lie roughly in the range of 30− 70%. The
details are given in Appendix A.1.4.
I. Impute (di,Wi,yim) given (φ, ν, Yo) from their posterior distribution (20) given in Appendix
A.1.1.
PX1. Update (d1, . . . , dn, γ1, . . . , γp) as (gd1, . . . , gdn, γ1/g, . . . , γp/g), where g is drawn from its
posterior distribution given in Appendix A.1.2.
PX2. Update (W1, . . . ,Wn, ψ1, . . . , ψp)→ (hW1, . . . , hWn, ψ1/h, . . . , ψp/h), where H = h2 is
drawn from its posterior distribution given in Appendix A.1.3.
Notes:
1. Steps P2 and I form a block (ν,Wi’s, di’s,yim’s) in the sense that they are drawn from
π(ν,Wi’s, di’s,yim’s|φ, Yo)
∝ π(ν|φ, Yo)
n∏
i=1
{π(Wi|ν,φ, Yo)π(di|Wi, ν,φ, Yo)π(yim|di,Wi, ν,φ, Yo)} .
The use of the blocking technique generally reduces the autocorrelation between posterior samples and
speeds up the convergence of the Markov chain.
In the above approach, sampling ν requires calculating the marginal density of yio. As described
in Appendix A.1.4, the density of yio can be computed without matrix inversion for monotone missing
data. Therefore, one alternative strategy is to replace steps P2 and I by sampling (ν,Wi’s, di’s) from their
posterior distribution π(ν,Wi’s, di’s|φ, Yo, Ym) using the method described in Appendix A.1.4 (applied
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after the intermittent missing data yim’s are filled in), and imputing yim’s from the posterior distribution
π(yim|di,Wi,yio,φ, ν) given in Equation (21) in Appendix A.1.1.
Another strategy is to keep step I unchanged, but update ν from its conditional posterior distribution
given (φ, Yo, Ym,Wi’s, di’s) via the MH sampler in step P2
π(ν|φ, Yo, Ym,Wi’s, di’s) ∝ π(ν) (ν/2)
nν/2
Γn(ν/2)
[
n∏
i=1
di
]ν/2−1
exp
[
−ν
∑
i di
2
]
I(ν > νl).
The per step computational time is reduced, but it may take many more iterations for the algorithm to
converge with larger autocorrelation between the posterior samples of ν.
2. Steps PX1 and PX2 are the generalized Gibbs samplers45,46 used to accelerate the convergence of the
algorithm. Omitting the two steps does not alter the stationary distribution of the Markov chain. Inclusion
of these steps tends to improve the mixing of the chain.
3. In step P1, we can also draw (θj , γj) via the MH sampler based directly on the Student’s
t prior for ψ
j
’s (dψj is integrated out of the prior). The candidate (θ
∗
j , γ
∗
j ) is drawn
from γ
nj+n0+2j+(r
∗+1)−p−3
2
j exp
[
− γj2 θ˜′j(Ej +
∑
i≤nj dix˜ijx˜
′
ij)θ˜j
]
, and accepted with probability
min

1,
[
(1 +
8γjψ
2
j
pi2 )/(1 +
8γ∗j ψ
∗2
j
pi2 )
]0.75
, where Ej is calculated at dψj ≡ 0. The sampling schemes
for g andH = h2 in steps PX1 and PX2 need to be updated accordingly.
The MDA algorithm for MMRM-st is an extension of Tang’s algorithm20 for MMRM-n. It can be
easily adapted for MMRM-sn and MMRM-t. The details are given in Appendices A.2 and A.3. In
MMRM-n and MMRM-t, we can use the inverse Wishart distribution, Jeffrey’s prior or the hierarchical
prior of Huang and Wand49 for Σ. The latter two priors are noninformative and lead to similar estimates.
Whether the inverse Wishart distribution is informative or not depends on the choice of the prior
parameters53.
4 MDA algorithm for a more general MMRM
In model (10), the fixed effects can vary freely over time, and there is a covariate by visit interaction for
each covariate. It is a special case of the following more general model
yij =
R∑
k=1
ηkzikj +
q∑
k=1
αkjxik + ξij for j = 1, . . . , p. (15)
The covariates can be split into two disjointed sets. The set X includes those time invariant covariates
xik’s whose effects vary over time. In the setZ , the value of the covariate zikj may change over time, but
its effect ηk remains constant over time. As illustrated in Tang
20, a covariate inX can be transformed into
p covariates in Z . Either the set X or Z could be empty. Whenever possible, we shall keep the covariates
in X to improve the efficiency of the MDA algorithm20.
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Similarly, model (15) can be factorized as the following sequential regression models
yij ∼ N
(
R∑
k=1
ηkzikj +
Q∑
k=1
αkjxik +
j−1∑
t=1
βjtyit, (diγj)
−1
)
for j = 1, . . . , p, (16)
where zikj = zikj −
∑j−1
t=1 βjtzikt, and αkj = αkj −
∑j−1
t=1 βjtαkt.
The MDA algorithm for model (10) can be adapted for model (15) with the following minor
modifications
1. In step P1, update x˜ij as (xi1, . . . , xiQ, y˜i1, . . . , y˜ij)
′, where y˜ij = yij −
∑R
k=1 ηkzijk . As
mentioned in Appendices A.1.1 and A.1.4, some quantities [i.e. y∗ij and rj ] shall be defined
according to model (15) instead of model (10).
2. A step P1b is added after step P1 to draw η by Gibbs sampler. Let zj be a nj × R matrix
whose ik-th entry is zijk , yij = yij −
∑
Q
k=1 αkjxik −
∑j−1
t=1 βjtyit, yj = (y1j , . . . , ynjj
)′, and
Dij = Diag(d1, . . . , dnj ). Under the prior η = (η1, . . . , ηR)
′ ∼ N(η0, Vη0) [note that π(η) ∝ 1
as V −1η0 → 0], the posterior distribution of η is normal
π(η|φ, ν,Wi’s, di’s, Yo, Ym) ∝ π(η) exp

−1
2
p∑
j=1
γj(yj − zjη)′Dij(yj − zjη)


∝ N(ηˆ, Vˆη),
where Vˆη = [
∑p
j=1 γjz
′
jDijzj + V
−1
η0 ]
−1, and ηˆ = Vˆη[
∑p
j=1 γjz
′
jDijyj + V
−1
η0 η0].
5 Imputations of missing data due to dropout
This section discusses the imputation of the dropout missing data in MMRM and PMMs. A common
feature of these models is that they assume the same marginal distribution for the outcomes prior to
dropout. That is, the observed data (yio’s) distributions are identical in PMMs and MMRM, and the
intermittent missing data (yim’s) are MAR.
We focus on model (16) since model (11) is a special case with η1 = . . . = ηR = 0. The distribution
of yi for subjects in pattern s can be decomposed as
f(yi) =

 s∏
j=1
f(yij |zij ,φ,η, ν)

H(yiw |yio,yim,φ,η, ν) (17)
whereH(yiw|yio,yim,φ,η, ν) is the conditional distribution of yiw given (yio,yim). The missing data
distribution H(·|·) may depend on some additional parameters φ2 to capture the deviation from MAR.
Since the observed data do not provide information about φ2, we set φ2 at some prespecified values, and
suppress φ2 in the notation
20.
The joint likelihood for (si,yio,yim,yiw)’s can be written as the product of the likelihood for the
pattern si’s and the likelihood for (yio,yim,yiw)’s. If the parameters indexing the two likelihoods are
Prepared using sagej.cls
MDA algorithm for multivariate skew-t regression 13
separable with independent priors, they are independent in the posterior distribution. Therefore, the
posterior distribution of (yim’s,yiw’s,φ,η, ν) is given by
π(yim’s,yiw’s,φ,η, ν|Yo, si’s)
∝
[
π(φ)π(η)π(ν)
n∏
i=1
f(yio,yim|φ,η, ν)
]
ntot∏
i=1
H(yiw|yio,yim,φ,η, ν).
(18)
The marginal posterior distribution of (yim’s,φ,η, ν) is π(φ)π(η)π(ν)
∏n
i=1 f(yio,yim|φ,η, ν), and
they can be sampled using the MDA algorithm A through the introduction of the latent variables
(di,Wi)’s. We can then impute yiw’s from H(·|·) after the MDA algorithm converges. All arguments
are essentially identical to that in Tang14,20.
5.1 MMRM (MAR)
Under MAR, the conditional distribution of yiw given the historical outcomes (yio,yim) is the same
between dropouts and subjects who remain in the trial. By Lemma 1, for subjects in pattern s, yiw can
be imputed sequentially from
yij =
R∑
k=1
ηkzikj +
q∑
k=1
αkjxik + ψjWi +
j−1∑
t=1
βjtyit +
1√
di
εj for j ≥ s+ 1,
where ηk’s, αkj ’s, ψj’s, βjt’s, γj’s, and (Wi, di,yim) are the posterior samples from theMDA algorithm,
and εj ∼ N(0, γ−1j ). We can also impute yiw = (yi,s+1, . . . , yip) in matrix form as
yMARiw = U
−1
s22


∑R
k=1 ηkzi,k,s+1 +
∑q
k=1 αk,s+1xik + ψs+1Wi +
∑s
t=1 βs+1,tyit +
εs+1√
di
. . .∑R
k=1 ηkzikp +
∑q
k=1 αkpxik + ψpWi +
∑s
t=1 βptyit +
εp√
di

 ,
where Us22 is defined in Lemma 1.
5.2 Delta-adjusted imputation
In the delta-adjusted PMMs, the mean response at visit j > s among subjects in treatment group g,
pattern s will be shifted by a fixed value ∆sgj compared to those who remain on the treatment at visit
j 13,14
yij = ∆sgj +
R∑
k=1
ηkzikj +
q∑
k=1
αkjxik + ψjWi +
j−1∑
t=1
βjtyit +
1√
di
εj for j ≥ s+ 1.
The imputed values can be conveniently obtained from that under MAR as
yDELiw = y
MAR
iw + U
−1
s22 (∆sg,s+1, . . . ,∆sgp)
′.
Prepared using sagej.cls
14 Journal Title XX(X)
Sensitivity analysis can be performed by varying the parameters ∆sgt’s. To reduce the amount of
sensitivity parameters, we set ∆sgt = ∆g . But other choices are possible
14. The delta adjustment is
applied by conditioning on the historical outcomes (yi1, . . . , yis). The adjustment can also be performed
without conditioning on the historical outcomes14, i.e., yDELiw = y
MAR
iw + (∆sg,s+1, . . . ,∆sgp)
′.
The delta-adjusted imputation forms the basis of the tipping point analysis. The tipping point analysis
assesses how severe the deviation from MAR can be in order to overturn the MAR-based conclusion.
It has been popularly used in new drug applications16. The delta adjustment can be applied only to
the experimental arm14,20 by assuming MAR in the control arm (∆0 = 0) or to both arms
23,54. The
MI analysis is repeated over a sequence of prespecified values for ∆1 given ∆0 = 0 or over a range
of pre-specified values for (∆0,∆1) in order to find the region in which the treatment comparison
becomes statistically insignificant. If the insignificance region is deemed clinically implausible, the
primary conclusion is said to be robust to deviations from MAR.
5.3 Control-based imputation
The control-based imputation assumes that after dropout, the future statistical behavior among subjects
in the experimental arm is similar to that of control subjects, and that the missing data are MAR in the
control group. Therefore, the missing data yiw’s in the experimental arm can be imputed by borrowing
information from the control arm.
The idea was firstly proposed in the seminal paper by Little and Yau11, and was later extended by a
number of authors12–14,20,23,55–58 for different types of response variables. Several popular control-based
imputation strategies include the jump to reference (J2R), copy increment in reference (CIR), and copy
reference (CR).
5.3.1 Jump to reference (J2R) The J2R approach assumes that once subjects in the experimental arm
cease the treatment, their mean responses jump to that of the control subjects. The model essentially
assumes that immediately upon withdrawal from the experimental treatment, all benefit from the
treatment is gone12,13.
In J2R, yiw can be imputed as
yJ2Riw = y
MAR
iw − (δs+1, . . . , δp)′ gi.
Let’s demonstrate the fact by using MMRM-st as an example. Suppose the distribution of yi in
MMRM is ST [(µCi1 + δ1gi, . . . , µ
C
ip + δpgi),ψ,Σ, ν], where µ
C
ij =
∑r
k=1 ηkzijk +
∑q−1
k=1 αkjxik and
δj is the treatment effect at visit j. In J2R, the distribution of yi is ST [(µ
C
i1 + δ1gi, . . . , µ
C
is +
δsgi, µ
C
i,s+1, . . . , µ
C
ip),ψ,Σ, ν], and the treatment effect vector is (δ1, . . . , δs, 0, . . . , 0) in pattern s. By
Lemma 1c, the conditional distributions of yiw given (yi1, . . . , yis) in MMRM and J2R differ only in the
location parameters, and the difference is (δs+1gi, . . . , δpgi)
′.
5.3.2 Copy Increment in Reference (CIR) In CIR, the mean profile after dropout in the
experimental arm is assumed to be parallel to that of control subjects. The treatment benefit prior
to withdrawal is maintained in CIR. It is suitable for modeling the effectiveness of a disease
modifying treatment12,13. In pattern s, the distribution of yi is ST [(µ
C
i1 + δ1gi, . . . , µ
C
is + δsgi, µ
C
i,s+1 +
δsgi, . . . , µ
C
ip + δsgi),ψ,Σ, ν], and the treatment effect vector is (δ1, . . . , δs, δs, . . . , δs). We can impute
yiw as
yCIRiw = y
J2R
iw + (δs, . . . , δs)
′ gi = yMARiw − (δs+1 − δs, . . . , δp − δs)′ gi.
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5.3.3 Copy Reference (CR) Under the CR assumption, the missing data distribution of yiw given
(yi1, . . . , yis) among dropouts from the experimental arm is the same as that of control subjects. The
missing data distribution for dropouts from the experimental arm can be obtained on basis of Lemma 1 by
assuming that they received the control treatment since randomization, and had the response distribution
ST [(µCi1, . . . , µ
C
ip)
′,Σ, ψ, ν]. The true joint distribution of yi = (yi1, . . . , yip)′ is complicated. For the
purpose of missing data imputations, we can firstly draw (d∗i ,W∗i ) given (yi1, . . . , yis) using Lemma 1a,
and then impute yiw given (yi1, . . . , yis, d
∗
i ,W∗i ) using Lemma 1b or 1c.
In CR, (d∗i ,W∗i ) among dropouts from the experimental arm needs to be drawn on basis of the control
mean. But in MMRM (MAR), delta-adjusted imputation, J2R and CIR, there is no need to regenerate
(d∗i ,W∗i ) since it has the same posterior distribution as (di,Wi) from the MDA algorithm.
6 Numerical examples
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(a) data with 30 subjects simulated from yi ∼ SN(0.5gi +
0.5xi, 0.25, 0.5)
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(b) data with 30 subjects simulated from yi ∼ SN(0.5gi +
0.5xi, 1, 0.5)
Figure 1. Posterior densities of the intercept, ψ and δ = λ√
1+λ2
in the univariate SN regression
6.1 Multimodality in the SN regression
In the univariate SN regression, the expected Fisher information matrix is singular24 at λ = ψ/σ = 0. As
a consequence, the empirical distribution of the MLE, and the posterior distribution of the parameter in
Bayesian inference are often bimodal41,42 when λ is near 0. Liseo and Parisi43 raises a concern that the
Gibbs sampler chain can easily get stuck in one of the modes for multimodal posterior distributions.
This does not appear to be a concern in our algorithm possibly because we sample (θj , γj)’s
simultaneously using the blocking scheme. The Gibbs sampler can be highly inefficient if the intercept
and ψ
j
are sampled separately because they are highly correlated. For illustrative purposes, we generate
two datasets of size n = 30 from yi ∼ SN(α1 + α2xi + α3gi, σ2, ψ). Figure 1 plots the posterior
densities of α1, ψ and δ =
λ√
1+λ2
. They are clearly bimodal or multimodal for both datasets.
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6.2 Analysis of an antidepressant trial using controlled imputation
The antidepressant trial has been analyzed by several authors to illustrate the missing data
methodologies13,14,20,23,51,56. The Hamilton 17-item rating scale for depression (HAMD17) is collected
at baseline and weeks 1, 2, 4, 6. The dataset consists of 84 subjects on the experimental treatment
and 88 subjects on placebo. The number of subjects who discontinue the trial early is 20 (24%) in the
experimental arm, and 23 (26%) in the placebo arm.
The purpose of the analysis is to estimate the effect of the experimental product compared to placebo
on the improvement in HAMD17 from baseline to week 6. We impute the missing response under MAR
and MNAR by MMRM-n, MMRM-t, MMRM-sn and MMRM-st. The covariate set X includes the
intercept, baseline HAMD17 score yi0 and treatment status gi. The covariate set Z is empty. In each
model, m = 10, 000 datasets are imputed from every 100th iteration after a burn-in period of 100, 000
iterations. The trace plots and autocorrelation function (ACF) plots indicate approximate convergence of
these MDA algorithms. In practice, it is prudent to use a long burn-in period to ensure that the Markov
chain reaches the stationary distribution, and this is particularly important in the pharmaceutical industry
where the analysis is done by programmers without much knowledge about the Bayesian analysis20. We
analyze the outcome at week 6 by the analysis of covariance (ANCOVA) for each imputed dataset, and
the results are combined for inference using Rubin’s rule59.
We employ the deviance information criterion (DIC60) to compare the four MMRMs. The DIC is
defined as
DIC = D(ηˆ, φˆ, νˆ) + 2pD = D(ηˆ, φˆ, νˆ) + 2[D¯(η,φ, ν)−D(ηˆ, φˆ, νˆ)]
= 2m−1
m∑
b=1
D(η(b),φ(b), ν(b))−D(ηˆ, φˆ, νˆ),
where D(η,φ, ν) = −2∑ni=1 log[f(yio|η,φ, ν)], (η(b),φ(b), ν(b)) is the b-th posterior sample
collected after the burn-in period, (ηˆ, φˆ, νˆ) = m−1
∑m
b=1(η
(b),φ(b), ν(b)), and D¯(η,φ, ν) =
m−1
∑m
b=1D
(
η(b),φ(b), ν(b)
)
. In DIC, D(ηˆ, φˆ, νˆ) measures the model fit while pD estimates the
effective number of parameters or model complexity60. Overall, a smaller DIC indicates a better model
fit.
MMRM-n MMRM-t MMRM-sn MMRM-st
mean± SE t (pvalue) mean± SE t (pvalue) mean± SE t (pvalue) mean± SE t (pvalue)
MAR −2.80 ± 1.11 −2.54 (0.012) −2.81 ± 1.13 −2.49 (0.014) −2.80 ± 1.14 −2.47 (0.015) −2.81 ± 1.11 −2.54 (0.012)
J2R −2.13 ± 1.12 −1.90 (0.059) −2.11 ± 1.14 −1.85 (0.066) −2.14 ± 1.15 −1.87 (0.064) −2.16 ± 1.12 −1.93 (0.056)
CR −2.37 ± 1.10 −2.15 (0.033) −2.37 ± 1.11 −2.13 (0.035) −2.37 ± 1.12 −2.11 (0.036) −2.38 ± 1.10 −2.16 (0.032)
CIR −2.45 ± 1.10 −2.23 (0.027) −2.46 ± 1.12 −2.20 (0.030) −2.45 ± 1.13 −2.17 (0.032) −2.47 ± 1.10 −2.25 (0.026)
DEL(a) −2.05 ± 1.13 −1.82 (0.071) −2.05 ± 1.15 −1.78 (0.076) −2.06 ± 1.16 −1.78 (0.078) −2.07 ± 1.13 −1.83 (0.069)
Table 1. MI treatment effect estimates at week 6 in sensitivity analysis of an antidepressant trial using
controlled pattern imputations:
(a) a delta adjustment of −2 is applied to subjects in the experimental arm after treatment discontinuation.
MAR is assumed in the placebo arm.
Table 1 reports the MI results. The DIC is 3526.97 for MMRM-n, 3528.58 for MMRM-t, 3514.55 for
MMRM-sn and 3514.43 for MMRM-st. MMRM-st appears to fit the data slightly better and give slightly
more significant treatment effect estimates than MMRM-n, MMRM-t and MMRM-sn.
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(b) The symbols indicate the range of pvalue: ‘v’
pvalue< 0.0001, ‘x’ pvalue< 0.001, ‘o’ pvalue <
0.01, ‘*’ pvalue< 0.05
Figure 2. Plot of -log10(pvalue) in the tipping point analysis of an antidepressant trial with delta adjustment in
the experimental arm (left) and in both treatment groups (right)
As will be discussed in the last section, we suggest conducting the missing value imputation based
directly on MMRM-st without a model selection in large trials. Below we illustrate the tipping point
analysis on basis of MMRM-st. Figure 2(a) plots the result when the adjustment is applied only in
the experimental arm (i.e. MAR in the placebo arm). The treatment comparison becomes insignificant
(pvalue> 0.05) if the mean response among dropouts from the experimental arm is at least 1.4 point
worse at each visit compared to subjects who remain on the experimental treatment. Figure 2(b) plots
the analysis with the delta adjustment in both arms. The treatment effect becomes insignificant only in a
small region where∆0 −∆1 ≥ 1.4 roughly holds.
6.3 Framingham cholesterol data
We analyze the Framingham cholesterol data to assess the robustness of MMRM-n, MMRM-t, MMRM-
sn and MMRM-st in the presence of outliers. The data were first explored by Zhang and Davidian28
to characterize changes in the cholesterol level over time, and assess the effect of age and gender. Two
hundred subjects are randomly selected from the Framingham study. The cholesterol levels are measured
at the beginning of the study and then every 2 years for 10 years.
In the literature28,34,35,61,62, this dataset was typically fitted by a linear growth (LG) model with baseline
age and gender as fixed effects and subject-specific random intercept and slopes, where the random effects
and/or random errors are modeled by non-normal distributions. We provide an alternative approach to
analyze the data
yij = η1 + η2 tij + η3 sexi + η4 agei + ξij ,
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where yij is the cholesterol level divided by 100 at visit j for subject i, and tij is (time− 5)/10 with
time measured in years from baseline. To compare the fixed effect estimates with those reported in the
literature, we put 4 covariates {1, tij , sexi, agei} in the set Z , and no covariate in X . Another approach
is to set X = {1, sexi, agei} and Z = {tij}, and it makes fewer assumptions on the relationship of age
and gender with the cholesterol level. The within subject dependence is modeled by the multivariate
normal, t, SN or ST distributions. Our model is more general than the LG model in that we don’t assume
a structured covariance matrix.
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi1
D
en
si
ty
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi2
D
en
si
ty
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi3
D
en
si
ty
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi4
D
en
si
ty
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi5
D
en
si
ty
0.0 0.4 0.8
0
1
2
3
4
5
6
7
psi6
D
en
si
ty
5 15
0.
00
0.
10
0.
20
0.
30
d.f.
D
en
si
ty
Figure 3. Marginal posterior densities for the skewness (ψ1, . . . , ψ6) and df (ν) parameters in the analysis of
the cholesterol raw data using MMRM-st
In the MDA algorithm, we collect 20, 000 posterior samples from every 100th iteration after a burn-in
period of 100, 000 iterations. The convergence of the Markov chain is evidenced by the trace plots and
ACF plots in all four models.
Table 2 displays the parameter estimates and DIC. According to the DIC criterion, MMRM-st provides
the best fit to the raw data. Figure 3 plots the marginal posterior densities for the skewness and df
parameters in MMRM-st. The posterior samples of ν concentrate in the interval [5, 15], indicating heavy
tails in the observed data. The posterior densities for ψ1, . . . , ψ6 all concentrate in the interval [0.1, 0.7],
indicating the skewness in the cholesterol level at each visit. As shown in Table 2, the 95% credible
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intervals for ψ
3
, . . . , ψ
6
cover 0, evidencing that the skewness of the cholesterol level reduces after
adjusting for the historical outcomes at previous visits.
In these MMRMs, the regression coefficients (particularly the intercept η1) do not have the same
interpretation because the latent variable W ∼ N+(0, 1) does not have zero mean. Let Ei = η1 +
η2 tij + η3 sexi + η4 agei. In bothMMRM-n andMMRM-t, the mean response is assumed to be constant
over time, Ein = Eit = (Ei, Ei, Ei, Ei, Ei, Ei)
′. In MMRM-sn and MMRM-st, the mean response is
not constrained to be the same across visits. The mean response profile is given by Eisn = Ein +√
2
pi (ψ1, . . . , ψ6)
′ in MMRM-sn, and Eist = Ein +
√
ν
pi
Γ( ν−12 )
Γ( ν2 )
(ψ1, . . . , ψ6)
′ in MMRM-st. The Bayes
estimates of the fixed effects in MMRM-n and MMRM-t are close to the MLE from the normal LG
model reported by Zhang and Davidian28, and MMRM-t gives slightly narrower credible intervals for
the fixed effects than MMRM-n. Lachos et al35 analyzes the data using the robust LG model with
SN (or ST) random intercept and slope, and normal (or t) random error, which can be roughly viewed
as the submodels of the robust MMRM (15) with certain constraints on the covariance parameters Σ
and the skewness parameters ψ = (ψ1, . . . , ψp)
′. The estimated age and gender effects [ηˆ3 = −0.057
(SD: 0.049), ηˆ4 = 0.014 (SD: 0.003)] from the LG model with SN random effects are close to that
from MMSM-sn, while the LG model with ST random effects gives similar estimates of the age and
gender effects [ηˆ3 = −0.062 (SD: 0.045), ηˆ4 = 0.014 (SD: 0.003)] to MMRM-st. The estimate and
interpretation of the intercept η1 and slope η2 parameters are different in these models since the skewed
random variables do not have zero mean. Lachos et al63 assesses the performance of the robust LG
models in predicting future responses. The robust MMRMs show comparable prediction performance,
and the results are not shown due to limited space.
We evaluate the robustness of these MMRMs through the influence of the outliers on the parameter
estimates. For simplicity, the outlier values are generated by replacing yij with yij = yij + 8 for
j = 1, . . . , 6 in the first two subjects. The result is also displayed in Table 2. In MMRM-n, the estimates
of the regression coefficients and their 95% credible intervals for the between-subject covariates (i.e.
intercept η1, sex η3, age η4) change noticeably after the introduction of the outliers, but the estimate of
the time effect η2 is little changed. Similar behavior is observed in the maximum likelihood inference
by Zhang and Davidian28. In MMRM-sn, the outliers influence the estimates of the skewness parameters
ψˆ
j
’s and the 95% credit intervals for the regression coefficients. MMRM-t provides robust parameter
estimates except that the estimated df parameter gets smaller, indicating heavier tails in the presence
of outliers. In MMRM-st, the outliers affect the estimates of the df and skewness parameters, but the
estimation of the covariate effects is much less sensitive to the outliers.
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MMRM-n MMRM-t MMRM-sn MMRM-st
Framingham cholesterol raw data
η1 1.647± 0.148 [1.357, 1.937] 1.567± 0.141 [1.295, 1.846] 1.395 ± 0.140 [1.121, 1.668] 1.414 ± 0.133 [1.148, 1.674]
η2 0.275± 0.025 [0.227, 0.324] 0.277± 0.024 [0.230, 0.324] 0.332 ± 0.091 [0.146, 0.500] 0.296 ± 0.082 [0.128, 0.450]
η3 −0.063± 0.054 [−0.168, 0.043] −0.067± 0.051 [−0.167, 0.033] −0.056± 0.049 [−0.152, 0.039] −0.063 ± 0.046 [−0.154, 0.026]
η4 0.017± 0.003 [0.011, 0.024] 0.018± 0.003 [0.012, 0.025] 0.014 ± 0.003 [0.008, 0.021] 0.014 ± 0.003 [0.008, 0.020]
ψ
1
0.494 ± 0.065 [0.358, 0.609] 0.404 ± 0.061 [0.277, 0.517]
ψ
2
0.334 ± 0.123 [0.097, 0.584] 0.271 ± 0.091 [0.105, 0.460]
ψ
3
0.051± 0.120 [−0.172, 0.292] 0.073± 0.098 [−0.115, 0.269]
ψ
4
0.116± 0.145 [−0.148, 0.407] 0.109± 0.105 [−0.087, 0.320]
ψ
5
−0.225± 0.143 [−0.478, 0.083] −0.136 ± 0.116 [−0.353, 0.097]
ψ
6
−0.025± 0.168 [−0.348, 0.311] 0.023± 0.132 [−0.234, 0.288]
ν 8.532 ± 2.058 [5.472, 13.458] 8.091± 1.869 [5.275, 12.542]
DIC 348.65 310.56 339.285 296.01
Framingham cholesterol data with outliers generated in the first two subjects
η1 1.730± 0.356 [1.034, 2.425] 1.545± 0.147 [1.258, 1.834] 1.397 ± 0.190 [1.011, 1.756] 1.420 ± 0.139 [1.144, 1.689]
η2 0.276± 0.024 [0.229, 0.324] 0.279± 0.024 [0.234, 0.326] 0.322 ± 0.032 [0.260, 0.385] 0.292 ± 0.056 [0.181, 0.399]
η3 −0.019± 0.130 [−0.273, 0.236] −0.067± 0.053 [−0.171, 0.037] −0.050± 0.070 [−0.189, 0.089] −0.065 ± 0.047 [−0.157, 0.028]
η4 0.017± 0.008 [0.001, 0.033] 0.018± 0.004 [0.012, 0.025] 0.009 ± 0.004 [0.000, 0.017] 0.013 ± 0.003 [0.006, 0.019]
ψ
1
1.159 ± 0.067 [1.035, 1.296] 0.468 ± 0.056 [0.358, 0.578]
ψ
2
1.137 ± 0.249 [0.592, 1.613] 0.350 ± 0.101 [0.167, 0.563]
ψ
3
0.197± 0.390 [−0.522, 1.031] 0.107± 0.113 [−0.111, 0.341]
ψ
4
0.321± 0.461 [−0.484, 1.307] 0.138± 0.115 [−0.074, 0.379]
ψ
5
−0.060± 0.447 [−0.962, 0.903] −0.131 ± 0.128 [−0.368, 0.132]
ψ
6
−0.059± 0.424 [−0.966, 0.801] 0.020± 0.131 [−0.240, 0.283]
ν 4.957± 0.756 [3.648, 6.596] 5.318 ± 0.853 [3.873, 7.225]
DIC 699.60 402.50 544.95 371.94
Table 2. DIC and posterior mean ± standard deviation [95% credible interval] for the model parameters in the analysis of the Framingham
cholesterol raw data and data with outliers generated in the first two subjects :
[1] the estimates of the variance parameters (i.e. βjk ’s and γj ’s) are omitted due to the limited space.
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7 Discussion
We consider robust inference for skewed and/or heavy-tailed longitudinal data using MMRM-st,
MMRM-sn or MMRM-t. These robust regressions have some undesirable attributes, and the posterior
distributions can be improper with infinite estimates for some model parameters under diffuse priors.
We use the PC prior for the df parameter, Huang-Wand’s49 hierarchical prior for Σ, and reference prior
for the individual skewness parameter ψ
j
of y
ij
= yij −
∑j−1
t=1 βjtyit. An efficient MDA algorithm is
developed for Bayesian inference and missing data imputation. In practice, one may specify a different
prior that reflects the existing knowledge or has better statistical properties. The MDA algorithm can be
modified accordingly. For example, if a non-conjugate prior is used for the skewness parameters, they
can be drawn via an independent or random walk Metropolis sampler64 with candidates generated by the
proposed Gibbs scheme.
In clinical trials, usually only a few important covariates (e.g. baseline response, stratification factors)
are included in the model4,65. These covariates are typically completely observed. In case there are
some missing covariates, the MDA algorithm can be adapted to impute both the missing covariates and
responses based on their joint distribution23. In Lu66, the baseline covariates are constrained to have the
same mean across treatment groups in randomized trials. Relaxing this constraint simplifies the algorithm
without incurring efficiency loss in randomized trials (simulations unreported here), and makes it also
suitable for studies with baseline imbalance.
The MDA algorithm is used to perform the controlled imputations for MNAR sensitivity analyses of
longitudinal clinical trials. The assumptions about missing data are untestable given only the observed
data18. A control-based strategy (CR, J2R or CIR) can be selected according to the drug mechanism of
action (i.e. will the treatment benefit disappear after treatment discontinuation? how long will it take for
the benefit to disappear?). The missing data mechanism may vary across patients, and one can apply the
most conservative strategy (i.e. J2R) to patients who drop out due to lack of efficacy and safety issues.
Alternatively, one may conduct the tipping point analysis based on the delta-adjusted imputation. There
are many reasonable ways to assume how the response trajectory changes after treatment discontinuation.
The MDA algorithm is still suitable as long as the observed data distribution remains the same as that
under MAR.
In current clinical practice, it becomes more common to continue the data collection after treatment
discontinuation. If the data observed after treatment discontinuation are assumed to have the same
distribution as the missing data after dropout, they can be included in the controlled imputations by using
the proposed MDA algorithm with little modifications. In the CR and delta-adjusted imputations, we
replace the assigned treatment status by the actual treatment received at each visit (i.e. 0 after treatment
discontinuation) in models (11) and (16). In J2R and CIR, we need to use model (15), and code the actual
treatment status by p covariates in the covariate set Z .
There are several reasons to implement the controlled imputations via MI. The analysis of clinical trials
generally follows the intention-to-treat principle3,11, but the data are generated on an as-treated basis11.
The MI inference can accommodate different imputation and analysis models. Furthermore, auxiliary
variables and surrogate outcomes that are correlated with the response variables and the dropout process
may be used to improve the imputation23. Likelihood-basedmethods have been proposed for the control-
based PMM67. As demonstrated in the supplementarymaterials of Tang56, the likelihood-based approach
is asymptotically equivalent to a MI approach in which both imputation and analysis models follow the
as-treated principle, and hence may not be appropriate for the analysis of clinical trials. Furthermore, the
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standard maximum likelihood theory may not work in the SN and ST regressions since the asymptotic
distribution for the MLE of the skewness parameters can be multimodal for data close to normal41,42, and
the MLE of the skewness parameters may be infinite for skewed data41.
A variety of multivariate distributions have been proposed for skewed and heavy-tailed data. These
include several versions of SN / ST distributions summarized by Lee and McLachlan47, skew-slash
distribution35, skew-contaminated normal distribution35, and finite mixtures of these distributions47,48.
One popular semiparametric approach is based on the Dirichlet process mixture model68, which can be
represented as an infinite mixture model. We choose the SN and ST distributions developed by Azzalini
et al25,32 because they are easy to work with computationally and effective in handling non-normality
for practical purposes. The MDA algorithm can be extended to MMRM with residual errors modeled by
other non-normal distributions mentioned above. It is also possible to adapt the MDA algorithm as the
monotone expectation-maximization algorithm for maximum likelihood inferences in these models.
We employ the MMRM model (10) or (15) for missing data imputation, which can be reorganized
as a sequence of conditional models (11) or (16). We can also build the imputation process directly on
models (11) or (16). As discussed in Tang23, there are some advantages of using the sequential regression
models. First, there is no need to include all the historical outcomes (yi1, . . . , yij−1) as the predictors of
yij particularlywhen the number of response variables p is large. Second, one can incorporate interactions
between predictors into the conditional models.
In MMRM-st, the latent variables (Wi, di) are shared by all observations within a subject. It is
more parsimonious than the sequential approach based on the univariate ST regression developed in
our previous work23, in which p pairs of latent variables (Wij , dij)’s are introduced per subject. The
sequential ST regression allows the skewness of yij’s to be induced by different latent variables, and the
df to vary by visit / variable, and hence may be more suitable for multivariate data consisting of different
outcomes (e.g. cholesterol, weight) than MMRM-st. Although the sequential ST regression seems more
flexible, a large sample size is needed to accurately estimate69 the df parameters and detect the difference
in the df across visits since the likelihood function becomes flatter with increasing df. It may be preferable
to use MMRM-st to analyze longitudinal data with the same response variable collected repeatedly over
time if there is no big variation in the degrees of tail heaviness across visits.
Extensive research indicates that the analysis of non-normal outcomes based on the normality
assumption may produce inefficient inferences possible because the violation of normality tends to have
more impact on the estimation of the variance-covariance parameters and the variance of the fixed effects
than on the estimation of the fixed effects27 in both Bayesian inference35 and maximum likelihood
inference27,28,70. This is also observed in the Bayesian analysis of the cholesterol data using MMRM-
n. The Bayes parameter estimates in MMRM-st and MMRM-t are quite insensitive to the outliers.
As evidenced by the DIC criterion, MMRM-st provides the best fit to both the antidepressant trial
and cholesterol data. In the MI inference, we recommend imputing missing values using MMRM-st, and
there is no need to perform a model selection in large confirmatory trials. A model selection procedure
may pick up a wrong model, inflating the type I error rate71,72. In our early work23, simulation is
conducted for the analysis of bivariate continuous and binary outcomes. It shows that the MI estimates
from the ST regression have smaller bias and variance than that based on the normal regression for
non-normal continuous outcomes, while the two approaches have almost the same efficiency for normal
outcomes. There are numerical evidences that MMRM-st tends to outperform MMRM-n for non-
normal longitudinal continuous outcomes. Inference based on a reduced model can be misleading if the
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corresponding assumption does not hold23,27,73. We will conduct a formal simulation study to compare
these MMRMs after we find enough computational resources, and report the results elsewhere.
A future research direction associated with the robust MMRMs is to identify outliers or atypical
observations27,73. This may help us better evaluate the treatment effects (e.g. is the effect of the test
treatment driven by few subjects?). It is inappropriate to remove these atypical observations from the
analysis as it affects the accuracy and precision of parameter estimates70. In MI, we analyze the imputed
data by ANCOVA, which may not be robust to a severe deviation from normality74. The MI inference
may be improved by analyzing the imputed data using a robust approach such as the M-estimation75.
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A Appendix
A.1 Posterior distributions in the MDA algorithm
A.1.1 Posterior distribution of (di,Wi, yim) Let y˜im = (Wi,yim) andXi = (xi1, . . . , xiq ,y′io)′.
Let Uijo and Uijm be a partition of the (Q + si)× 1 vector (θj ,−1,0′si−j)′ according to the elements
inXi and y˜im. Let y
∗
ij = −U ′ijoXi for model (10). For model (15), y∗ij = −U ′ijoXi −
∑
R
k=1 ηkzikj .
The posterior distribution of (di,Wi,yim) is given by
π(di,Wi,yim|yio,φ, ν) ∝ f(di,Wi)

 si∏
j=1
√
diγj

 exp

− si∑
j=1
diγj(y
∗
ij − U
′
ijm y˜im)
2
2


∝ d
ν+si+1
2 −1
i exp
[
−di bd + (y˜im − µwi)
′Awi(y˜im − µwi)
2
]
∝

1 + (Wi−µwi1)
2
U2w11bd/ba
ba


− ba+12
G
(
di|ba + 1
2
,
bd + (Wi − µwi1)2L2w11
2
)
N
(
yim|µim, Uw22U
′
w22
di
)
(19)
subject toWi > 0, where m˜ = mi + 1, A0 is a m˜i × m˜i matrix with 1 at its (1, 1) entry and 0
elsehwere, Awi = A0 +
∑si
j=1 γjU
′
ijm
Uijm , the lower triangle matrix Lwi =
[
Lw11 0
Lw21 Lw22
]
satisfies
Awi = L
′
wiLwi , Lw11 is a scalar, Uwi =
[
Uw11 0
Uw21 Uw22
]
= L−1wi , Bwi =
∑si
j=1 γjU
′
ijm
y∗ij ,
Cwi = U
′
wiBwi , and µwi = A
−1
wi Bwi = UwiCwi =
[
µwi1
µwi2
]
, µim = µwi2 + Uw21Lw11(Wi − µwi1),
ba = ν + oi, B
′
wiA
−1
wiBwi = C
′
wiCwi and bd = ν +
∑si
j=1 γjy
∗2
ij − C′wiCwi . In SAS IML, Lwi can be
computed can use the following syntax
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index=mtilde:1;
Lwi = (root(Awi[index,index]))[index,index];
Equation (19) implies that we can draw (Wi, di,yim) sequentially from
d∗i ∼ G
(
ba
2
,
bd
2
)
, Wi|d∗i ∼ N+
(
µwi1,
U2w11
di
)
,
di|Wi, d∗i ∼ G
(
ba + 1
2
,
bd + (Wi − µwi1)2L2w11
2
)
,
yim|di,Wi, d∗i ∼ N
(
µim,
Uw22U
′
w22
di
)
.
(20)
The marginal distribution ofWi is t+
(
µwi1, U
2
w11
bd
ba
, ba
)
, but the marginal distribution of di is not
gamma due to the restrictionWi > 0.
The posterior distribution of yim can be equivalently written as
yim|di,Wi,yio,φ, ν ∼ N
(
µim,
Vym
di
)
, (21)
where h is the index of the first missing observation for subject i in pattern s, U˜ijm is a sub-vector of
(θj ,−1,0′si−j)′ corresponding to the elements in yim, y∗∗ij = y∗ij − ψjWi,
Vym = (
∑s
j=h γjU˜ijm U˜
′
ijm
)−1 and µim = Vˆym
∑s
j=h γjU˜ijmy
∗∗
ij .
A.1.2 Posterior distribution of g in step PX1 The posterior distribution of g with a Harr prior g−1 and
Jacobian gn−p is
pos(g) ∝ gn−pg−1 π
(
Ym, gd1, . . . , gdn,W, θ1,
γ1
g
, d1ψ , . . . , θp,
γp
g
, dpψ , ν|Yo
)
∝ gn−pg−1
n∏
i=1
{
(gdi)
ν+1
2 −1 exp
[
−g di(ν +W
2
i )
2
]}
p∏
j=1
{(
γj
g
)nw+2j+r−p−3
2
exp
[
−γjθ˜
′
jEj θ˜j
2g
]}
∝ g n(1+ν)−p(nw+r)2 −1 exp
[
−g
∑n
i=1 di(ν +W2i )
2
]
exp
[
−
∑p
j=1 γj θ˜
′
jEj θ˜j
2g
]
.
A.1.3 Posterior distribution of h in step PX2 The posterior distribution of h with a Harr prior h−1
and Jacobian hn−p is
pos(h) ∝ hn−ph−1 exp
(
−h2
∑n
i=1 diW2i
2
)
exp

−
∑p
j=1 γjψ
2
j
4djψ
pi2
2h2

 .
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The posterior distribution ofH = h2 is
pos(H) ∝ pos(h)
∣∣∣∣ ∂h∂H
∣∣∣∣ ∝ H n−p2 −1 exp
(
−H
∑n
i=1 diW2i
2
)
exp

−
∑p
j=1 γjψ
2
j
4djψ
pi2
2H

 .
A.1.4 Prior and posterior distributions of ν We firstly derive the PC prior for ν. The
Kullback-Leibler (KL) distance between the multivariate t distribution t(µ, ν−2ν Σ, ν) and the normal
distributionN(µ,Σ) is
KL(ν) =
∫
t
(
x|µ, ν − 2
ν
Σ, ν
)
log t
(
x|µ, ν − 2
ν
Σ, ν
)
dx
−
∫
t
(
x|µ, ν − 2
ν
Σ, ν
)
logφ(x|µ,Σ)dx
=
p
2
[
1 + log
(
2
ν − 2
)]
+ log Γ
(
ν + p
2
)
− log Γ
(ν
2
)
− ν + p
2
[
Ψ
(
ν + p
2
)
−Ψ
(ν
2
)]
.
since the first integration equals
log Γ
(
ν+p
2
)− log Γ ( ν2 )− ν+p2 [Ψ ( ν+p2 )−Ψ (ν2 )]− 12 log |Σ| − p2 log(ν − 2)− p2 log(π) by Kotz
and Nadarajah76, and the second integration equals − p2 log(2π)− 12 log |Σ| − p2 .
By the definition of the PC prior52, the density is λ exp(−λd(ν))
∣∣∣ ∂d(ν)∂ν ∣∣∣, where d(ν) =√2KL(ν).
The posterior distribution of ν is given by
π(ν|Σ,ψ, θj , γj) ∝ π(ν)
n∏
i=1
tp(yio|µio,Ωio, ν)
Tν+oi
[
λ∗
′
io(yio − µio)
√
ν + oi
ν + (yio − µio)′Ω−1io (yio − µio)
]
I(ν > νl),
where tp(yio|µio,Ωio, ν) ∝ Γ(
ν+oi
2 )
Γ( ν2 )ν
oi/2
[1 + (yio − µio)′Ω−1io (yio − µio)/ν]−
ν+oi
2 , and
λ∗io = Σ
−1
io ψio/
√
1 +ψ′ioΣ
−1
io ψio.
For subjects with no intermittent missing data, the skew-t density function can be computed without
matrix inversion using the following relationship λ∗
′
io(yio − µio) =
∑s
t=1 λtRtψt and
(yio − µio)′Ω−1io (yio − µio) =
∑s
t=1 λtr
2
t − [
∑s
t=1 λtrtψt]
2/[1 +
∑s
t=1 λtψ
2
t
], where
rj = yij −
∑j−1
t=1 βjtyit −
∑
Q
k=1 αkjxik for model (10) and
rj = yij −
∑j−1
t=1 βjtyit −
∑R
k=1 ηkzikj −
∑Q
k=1 αkjxik for model (15).
The candidate ν∗ is generated from log(ν∗ − νl) ∼ N [log(ν − νl), c2]. It will be accepted with
probability αν = min
{
1,
(ν∗−νl)pi(ν∗)
∏n
i=1 f(yio|θi,γi,ν∗)
(ν−νl)pi(ν)
∏
n
i=1 f(yio|θi,γi,ν)
}
.
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A.2 Adaption of the MDA algorithm for MMRM-sn
For MMRM-sn (i.e. ν ≡ ∞), the MDA algorithmA can easily adapted by ignoring steps P2 and PX1,
and setting di ≡ 1 and d∗i ≡ 1 in drawing (θj , γj , dψj , ρj)’s and (Wi,yim)’s. For example, (Wi,yim)
in step I can be imputed by modifying the posterior distribution (20) as
Wi ∼ N+(µwi1, U2w11) and yim|Wi ∼ N(µim, Uw22U ′w22).
A.3 Adaption of the MDA algorithm for MMRM-t
For MMRM-t (i.e. ψ
j
≡ 0 for j = 1, . . . , p,Wi ≡ 0), the MDA algorithmA needs the following
modifications:
1. Step PX2 is no longer needed.
2. Step P1: RemoveWi from the model. Set dψj ≡ 0 and θj = (α1j , . . . , αqj , βj1, . . . , βjj−1)′. Sample
(θj , γj)’s from
π(θj , γj |di’s, ν, Yo, Ym) ∝ γ
nw+2j+r
∗−p−1
2 −1
j exp

−γj
2
θ˜′j(Ej +
∑
i≤nj
dix˜ijx˜
′
ij)θ˜j


for j = 1, . . . , p, where Ej is the (q + j)× (q + j) leading principle submatrix of the
(q + p)× (q + p) matrix E =
[
M Mα′0
α0M α0Mα
′
0 +Aw
]
and r∗ is the rank ofM . If the inverse Wishart
or Jeffrey’s prior (with fixed Aw and nw) instead of the hierarchical prior of Huang and Wand
49 is used,
step P0 shall be ignored.
3. Step I: draw di ∼ G
(
ba
2 ,
bd
2
)
and yim ∼ N(µwi , (diAwi)−1) since
π(di,yim|yio, ν,φ) ∝ f(di)d
si
2
i exp
[
−
∑si
j=1 diγj(y
∗
ij − U˜ ′ijmyim)2
2
]
∝
{
d
ν+oi
2 −1
i exp
[
−dibd
2
]}{
d
mi
2
i exp[−
di(yim − µwi)′Awi(yim − µwi)
2
]
}
,
where f(di) ∝ dν/2−1i exp(−diν), Awi =
∑si
j=1 γjU˜
′
ijm U˜ijm , Bwi =
∑si
j=1 γjU˜
′
ijmy
∗
ij ,
µwi = A
−1
wiBwi , ba = ν + oi and bd = ν +
∑si
j=1 γjy
∗2
ij −B′wiA−1wiBwi .
4. Step PX1: g is randomly drawn from
g
nν−p(nw+r
∗)
2 −1 exp
[
−g ν
∑n
i=1 di
2
]
exp
[
−
∑p
j=1 γj θ˜
′
jEj θ˜j
2g
]
.
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